Skip to content
Search

Latest Stories

Medicine reclassification: 6 health conditions identified for potential POM to P switch

6 health conditions identified for potential medicine reclassification
Pharmacy medicines provide people with easier access to treatments and encourage self-care (gettyimages)

Applications are invited for reclassification of prescription-only medicines to pharmacy medicines in these therapeutic areas 

The Department of Health and Social Care (DHSC) has published a list of health conditions and categories, where medicines could be reclassified from ‘available only on prescription’ (POM) to ‘available in pharmacy’ (P) or over-the-counter to support patients in self-care and improve access to much-needed medications.

Companies are now being encouraged to apply to the Medicines and Healthcare products Regulatory Agency (MHRA) for reclassification of relevant medicines in these areas.


Six broad health conditions have been identified as suitable for medicine reclassification based on international practice and real-world evidence. These include treatments for allergies, pain management, skin problems, digestive disorders, women's health and oral health.

These conditions were identified following consultation with the Conditions & Category Working Group, comprising government representatives, the NHS, clinicians, pharmacists, and industry experts, in 2024.

The Royal Pharmaceutical Society (RPS) is a member of the working group, which has worked with the MHRA to identify medicines that could be safely reclassified.

After receiving applications, the MHRA will assess each medicine product individually and will only grant reclassification if it is considered safe and appropriate.

Understand medicine reclassification

Reclassification allows medicines to move from prescription-only status to being available in pharmacies or over the counter. This shift enables patients to access necessary treatments more conveniently without having to visit their GP. It also empowers pharmacists to support patients in self-care for common conditions, reducing pressure on primary care services.

RPS President Professor Claire Anderson welcomed the department’s move to reclassify more medicines, noting that it will provide people with “easier access to treatments for a range of symptoms and encourage self-care.”

“Diagnosing and discussing health problems with patients and advising on the benefits and risks of treatment options are integral to the role of the pharmacy team.,” she said.

Professor Anderson emphasised that enabling POM to P switches is crucial in managing primary care demand, as it helps minimise unnecessary GP appointments and A&E attendances for minor conditions and ensures patients receive timely treatment from community pharmacies.

She assured that the RPS will continue working closely with the MHRA and manufacturers to provide guidance, ensuring patient safety.

Bosting self-care could save NHS £1.7 billion annually

Research conducted last year by PAGB, the consumer healthcare association, representing over-the-counter manufacturers, revealed that nearly a quarter of Britons still do not view self-care as their first option for easy-to-treat conditions. The study also highlighted that younger adults tend to lack the confidence in self-care that older generations have.

Michelle Riddalls, CEO of PAGB, stressed the importance of raising awareness about self-care and encouraging patients to seek advice from pharmacies for minor health concerns, helping to alleviate pressure on A&E departments.

Additionally, a study by Frontier Economics, commissioned by PAGB, estimated that greater reliance on self-care and the accessible expertise of high street pharmacies could save the NHS at least £1.7 billion annually in avoidable appointments and prescription costs.

Identified health conditions and medicine categories for reclassification

Conditions

  • Short term sleep aids
  • Oral health
  • Pain management (migraine, osteoarthritis, pain relief /joint pain)
  • Allergic rhinitis
  • Skin (acne, eczema, psoriasis)
  • Conditions that affect women’s health

Indications

Gastro:

  • Heartburn
  • Preventative indigestion
  • Stomach protection

Skin:

  • Acne
  • Actinic Keratoses
  • Eczema
  • Psoriasis

Women’s Health:

  • Heavy periods / Menorrhagia
  • Intimate fungal skin infections
  • UTI (non-antibiotic treatment)

The MHRA has confirmed that it will not consider reclassification applications for medicines containing opioids or antibiotics.

How to Apply

Companies interested in reclassifying a medicine can find detailed guidance on the GOV.UK website underMedicines: Reclassify Your Product. For further inquiries, they can contact the MHRA at variationqueries@mhra.gov.uk.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less